Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1712345...10...Last »

Google, Sanofi team up to improve diabetes care

Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes. Sanofi will work with Google’s life sciences team to collect, analyze and understand information impacting diabetes, which is expected to affect 592 million by 2035, according to the International Diabetes Federation. Sanofi’s diabetes product […]

Read More »

Right Place, Right Time: How Health Care and Wellness Companies Are Capitalizing on the Rapidly Growing Point of Care Communication Channel

Point of care (POC) communications, a historically small piece of the consumer-facing communications mix for health and wellness vendors in the U.S. represents a growing opportunity for brands to reach patients and caregivers in settings where they are especially focused on their health and wellness: at the doctor’s office, pharmacy and hospital.

Read More »

Bristol-Myers buys rights to acquire fibrosis drug developer

Drugmaker Bristol-Myers Squibb said it bought rights to a mid-stage fibrosis drug and its privately held developer for up to $1.25 billion, boosting its pipeline for drugs that treat tissue scarring. The deal gives Bristol-Myers access to Promedior Inc’s lead experimental drug, PRM-151, which is being tested to treat two types of fibrosis. PRM-151 is […]

Read More »

Pfizer to Terminate a Large Number of Employees in Korea

NEW YORK – Pfizer Inc.[2] (PFE[3]) is looking to terminate a number of its Korea-based employees as a means to increase efficiency in its management positions, Streetwise reported[4] this morning. The possible terminations come at a time when the small Korean branch has consistently shown strong growth despite a slowdown elsewhere, Streetwise said. Pfizer has […]

Read More »

Medtronic says trials find gene linked to sudden cardiac death

Two studies have identified a gene associated with potentially fatal abnormal heart rhythms, device maker Medtronic Plc said on Monday. The studies evaluated genetic information to identify gene abnormalities that may be associated with heart rhythms that could cause sudden cardiac death, the company said. Sudden cardiac death (SCD) is an unexpected death caused by […]

Read More »

Asterias’ stem cell therapy shows promise in study

Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The therapy, AST OPC-1, is the first product derived from human embryos to be tested on humans. Its success is a key step toward proving that embryonic […]

Read More »

Amicus Snaps up Scioderm and its Lead EB Drug in Deal Worth $847 Million

CRANBURY, N.J. – Amicus Therapeutics, Inc. (FOLD) inked a deal to acquire the privately-held biopharmaceutical company Scioderm Inc., Inc. in a deal worth up to $847 million, the company announced this morning.   The acquisition places Scioderm’s lead product candidate Zorblisa, a topical cream for the treatment of Epidermolysis Bullosa (EB) into Amicus’ rare and […]

Read More »

Bayer moves heart drug to final tests after mid-stage success

Bayer will move a new heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular medicine, after the experimental medicine proved better than an older rival in a mid-stage trial. Having done well with recently launched drugs like stroke prevention pill Xarelto and eye treatment Eylea, the German group is eager to […]

Read More »

Texas teen dies of rare brain-eating amoeba infection

A Texas teenager who contracted a rare brain-eating disease after swimming in a lake about 70 miles (110 km) north of Houston has died, according to his family and local media. The 14-year-old Michael Riley Jr., a junior Olympian and honor student, seemed to have contracted the disease after he went swimming on Aug. 13 […]

Read More »

Alnylam, Medicine Co.’s cholesterol drug lasts months after one shot

A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest. Results with Alnylam Pharmaceuticals and Medicines Co’s experimental product ALN-PCSsc highlight the competition for a market tipped […]

Read More »

Ralph Lauren Smart Shirt Will Measure Heart Rate And Calories Burned

Ralph Lauren’s big push into the world of wearable technology — a smart shirt that collects a range of data, including the wearer’s heart rate and number of calories burned — is set to hit retail Thursday. You may have first heard about the PoloTech shirt during last year’s U.S. Open, when the brand (the […]

Read More »

MEDA May Be Looking to Offload U.S. Operations Worth $1 Billion, Sources Say

GOTEBORG, Sweden — Could Meda AB be selling off its U.S. operations? Some sources are suggesting a deal could be in the works. Late Thursday, Bloomberg Business, citing “people familiar with the matter,” reported Sweden-based Meda was exploring options to sell off its U.S. operations which have an estimated value of $1 billion. Meda, which […]

Read More »

A Day After Investing $1.7 Billion in North Carolina, Novo Nordisk A/S Buys Two Indiana Biotech Companies

Novo Nordisk (NVO), headquartered in Copenhagen, Denmark, announced yesterday that it will buy Calibrium LLC and MB2 LLC, two private biopharma companies based in Indiana.   Calibrium, located in Carmel, Ind., focuses on developing drug candidates for diabetes and related metabolic diseases. It was co-founded by Fritz French, the company’s chief executive officer, and Richard […]

Read More »

Lilly Lung-Cancer Drug Stirs Price Debate

An experimental Eli Lilly (LLY 3.26 %) & Co. lung-cancer drug hasn’t reached the market, but some doctors are already arguing its price should be below average because the drug extended patient lives by only six to seven weeks in a clinical trial.   The pre-emptive price proposal—published on Thursday by the medical journal JAMA […]

Read More »

Johnson & Johnson to Open New HQ in Tampa, Bringing 500 New Jobs

Pharmaceutical powerhouse Johnson & Johnson (JNJ) will open a new $23.5 million North American shared services headquarters in Tampa, Florida Gov. Rick Scott‘s office announced Thursday.   The new site is expected to bring 500 jobs to Florida’s gulf coast and is expected to be operational sometime in the middle of 2016. Johnson & Johnson […]

Read More »

AMCP Is Disappointed in FDA’s Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products

ALEXANDRIA, Va., Aug. 27, 2015 /PRNewswire-USNewswire/ — The Academy of Managed Care Pharmacy (AMCP) is disappointed in the Food and Drug Administration’s (FDA’s) draft guidance and proposed rule that calls for biologics, including reference products and biosimilars, to bear a nonproprietary name with an FDA-designated suffix. For several years, AMCP has been seeking a decision from the […]

Read More »

FDA approves Amgen’s cholesterol-lowering drug Repatha

The U.S. Food and Drug Administration on Thursday approved Amgen Inc’s Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease. Last month the FDA approved a similar drug from Regeneron Pharmaceuticals Inc and Sanofi SA. The drugs belong to a potent new class of injectable LDL-lowering drugs known as […]

Read More »

High blood pressure in pregnancy tied to family risk

For women with pregnancy-related high blood pressure, the higher risk of hypertension that follows them through life may be due not just to the episode in pregnancy but also to family risk factors, researchers say. Their study looked at 252 women who had high blood pressure during pregnancy, as well as their sisters and brothers […]

Read More »

U.S. vaccination rates high, but pockets of unvaccinated pose risk

The vast majority of U.S. kindergarten-age children are vaccinated against preventable diseases but sizable pockets of unprotected children still exist, posing a public health threat, according to a government study.   Only 1.7 percent of U.S. parents of kindergartners sought exemptions in 2014 from laws requiring children be vaccinated, according to the U.S. Centers for […]

Read More »

Long working hours tied to stroke risk

People who work at least 55 hours a week are significantly more likely to eventually suffer a stroke than people who work 35 to 40 hours a week, a recent study suggests. Previously, the same research team had linked longer working hours with an increased risk of type 2 diabetes, but only for those in […]

Read More »

Page 1 of 1712345...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom